Episode 323 ASCO24: TDXD in Bladder Cancer

Shilpa Gupta joins us to discuss an X poll revealing equipoise about treatment approaches to resected high-risk upper tract urothelial cancer (UTUC). 

Rob Dreicer joins the show to discuss the FDA approval of Lutetium Lu 177 in the mHSPC space and how to contextualize the benefit/risk 

Today’s episode is focusing on bladder cancer - what you need to know about the pathology, presentation, diagnostic work-up, staging, treatment, and rarer upper GU tract presentations.

This episode covers bladder cancer.

Written notes can be found at https://zerotofinals.com/surgery/urology/bladdercancer/ or in the urology section of the Zero to Finals surgery book.

The audi ...

In this episode, we review the high-yield topic of Bladder Cancer from the Oncology section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets 

Hosts Drs. Craig Peters and Lou Kavoussi speak with Dr. Elisabeth Sebesta about her contribution to the upcoming 13th edition of Campbell-Walsh-Wein Urology, which covers an array of new information on patients with neurogenic bladder dysfunction. Dr. Sebesta is an Assistant Prof ...  Show more